(Q34396312)

English

Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit